Publication | Closed Access

Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome

Alzheimer's DiseasePsychiatryDementiaOther TypesGfap LevelsVascular DementiaFrontotemporal DementiaNeurochemical BiomarkersNeurologyNeuroscienceNeurodegenerationCerebral Blood FlowNeuropathologyMedicineBrain Pathology